Literature DB >> 12379107

Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate.

Stefania Violini1, Vijay Sharma, Julie L Prior, Mary Dyszlewski, David Piwnica-Worms.   

Abstract

Membrane permeation peptides, such as Tat basic domain, have emerged as useful membrane transduction agents with potential utility in therapeutic delivery and diagnostic imaging. While generally thought to universally permeate all cells by a nonselective process, the mechanism of membrane transduction remains poorly characterized. To examine vectorial transport properties of Tat basic domain in well-differentiated epithelial cells possessing tight junctions, L and D stereoisomers of Tat(48-57) peptide conjugates labeled with (99m)Tc were quantitatively analyzed in confluent monolayers of MDCK renal epithelial and CaCo-2 colonic carcinoma cells grown in transwell configurations. In both cell lines, vectorial transepithelial apparent permeability coefficients (P(app)) for L- and D-[(99m)Tc]Tat-peptides ranged from 30 to 70 nm/s, comparable to values for the macromolecular impermeant marker inulin in both apical-to-basolateral and basolateral-to-apical directions, but 100-fold less than the P(app) values for propranolol, a highly permeable control compound. Upon direct instillation of [(99m)Tc]Tat-peptide into the urinary bladder of living rats in vivo, no transepithelial permeation into other tissues was identified. Furthermore, MDCK and CaCo-2 cells showed a complete lack of intracellular accumulation of fluorescein conjugated Tat-peptide. However, translocation into cells was induced by treatment with plasma membrane permeabilizing agents such as digitonin and acetone/methanol, while cholesterol depletion with beta-methyl-cyclodextrin and metabolic inhibition with CCCP or 4 degrees C showed no effect. By contrast, in Hela and KB 3-1 cells, epithelial lines that do not form tight junctions in monolayer culture, baseline cytoplasmic and nucleolar accumulation was readily observed. Because all four cell lines expressed heparan sulfate proteoglycans, putative receptors for Tat basic peptides, we found no correlation between heparan sulfate and the permeation barrier observed in MDCK and CaCo-2 cells. The unanticipated presence of a permeation barrier to Tat-peptides in well-differentiated epithelial cells suggests the existence of cell-specific mechanisms for mediated translocation of these permeation peptides.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379107     DOI: 10.1021/bi026097e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  Passage of cell-penetrating peptides across a human epithelial cell layer in vitro.

Authors:  Maria E Lindgren; Mattias M Hällbrink; Anna M Elmquist; Ulo Langel
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

2.  Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models.

Authors:  Rachel Tréhin; Ulrike Krauss; Annette G Beck-Sickinger; Hans P Merkle; Hanne M Nielsen
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

Review 3.  Cell penetrating peptides in drug delivery.

Authors:  Eric L Snyder; Steven F Dowdy
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

4.  Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58).

Authors:  Rachel Tréhin; Ulrike Krauss; Roman Muff; Martina Meinecke; Annette G Beck-Sickinger; Hans P Merkle
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 5.  Inhibition of mitochondrial neural cell death pathways by protein transduction of Bcl-2 family proteins.

Authors:  Lucian Soane; Gary Fiskum
Journal:  J Bioenerg Biomembr       Date:  2005-06       Impact factor: 2.945

Review 6.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

7.  Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases.

Authors:  Christina Foerg; Urs Ziegler; Jimena Fernandez-Carneado; Ernest Giralt; Hans P Merkle
Journal:  Pharm Res       Date:  2007-03-03       Impact factor: 4.200

Review 8.  Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.

Authors:  Leena N Patel; Jennica L Zaro; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2007-04-19       Impact factor: 4.200

9.  A peptide for transcellular cargo delivery: Structure-function relationship and mechanism of action.

Authors:  Alexander Komin; Maxim I Bogorad; Ran Lin; Honggang Cui; Peter C Searson; Kalina Hristova
Journal:  J Control Release       Date:  2020-05-28       Impact factor: 9.776

10.  TAT-mediated intracellular protein delivery to primary brain cells is dependent on glycosaminoglycan expression.

Authors:  Melissa J Simon; Shan Gao; Woo Hyeun Kang; Scott Banta; Barclay Morrison
Journal:  Biotechnol Bioeng       Date:  2009-09-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.